Wolf, Anne - CAP 34
Investigation of the Mechanisms and Triggers leading to a Detrimental Retinal Immune Response during AAV-based Retinal Gene Therapy
Dr. Anne Wolf
Department of Ophthalmology
CMMC - PI - CAP 34
CMMC - Co-PI - B 07
show more…
Department of Ophthalmology
Introduction
For information about Dr. Wolf's research and work, please visit the following page: AG Wolf
Affiliations
Publications generated during 1/2023 - 12/2025 with CMMC affiliation
2025
- Behnke V, Wolf A, Hector M, Langmann T. C3aR1-Deletion Delays Retinal Degeneration in a White-Light Damage Mouse Model. Invest Ophthalmol Vis Sci. 2025 Jan 2;66(1):15. doi: 10.1167/iovs.66.1.15. PMID: 39775695; PMCID: PMC11717133.
2024
- Hector M, Langmann T, and Wolf A (2024). Translocator protein (18 kDa) (Tspo) in the retina and implications for ocular diseases. Prog Retin Eye Res100, 101249. doi:10.1016/j.preteyeres.2024.101249.
- Zech TJ, Wolf A, Hector M, Bischoff-Kont I, Krishnathas GM, Kuntschar S, Schmid T, Bracher F, Langmann T, and Furst R (2024). 2-Desaza-annomontine (C81) impedes angiogenesis through reduced VEGFR2 expression derived from inhibition of CDC2-like kinases. Angiogenesis27, 245-272. doi:10.1007/s10456-024-09906-y.